Evaluation of the degree of vascular inflammation in patients with metabolic syndrome;Evaluación del grado de inflamación vascular pacientes con síndrome metabólico

Arquivos Brasileiros de Cardiologia

Volumn 93, Issue 4, 2009, Pages

  Junqueira, Adriana Silva Monteiro ^a,c,d   Romêo Filho, Luiz José Martins ^a   Junqueira, Camillo De Léllis Carneiro ^b,c  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b UNIGRANRIO   (Brazil)

^c Rede Esho   (Brazil)

^d Laboratorio Sergio Franco   (Brazil)

Author keywords

C reactive protein; Interleukin 6; Metabolic syndrome

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; DIABETES MELLITUS; DISEASE MARKER; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MALE; METABOLIC SYNDROME X; RISK FACTOR; SMOKING; VASCULITIS; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; MIDDLE AGED; NONPARAMETRIC TEST;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 73449095756     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sociedade Brasileira de Cardiologia. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005; 84 (supl I): 3-28.
2. Reaven GM. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004; 33: 283-303.
3. Vidal J, Morinigo R, Codoceo VH, Casamitjana R, Pellitero S, Gomis R. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects. Int J Obes Relat Metab Disord. 2005; 29: 668-74.
4. da Luz PL, Laurindo FRM. Inflamação e aterosclerose. In: Nobre F, Serrano Jr, CV (eds). Tratado de Cardiologia SOCESP. São Paulo: Manole; 2005. p. 369-80.
5. Ridker PM. High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001; 103 (13): 1813-8.
6. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW. C-reactive , . protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004; 110 (4): 380-5.
7. Sociedade Brasileira de Cardiologia. V Diretrizes brasileiras de hipertensão arterial. Arq Bras Cardiol. 2007; 89 (3): 24-7.
8. Sociedade Brasileira de Cardiologia. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005; 84 (supl I): 3-38.
9. Guize L, Thomas F, Pannier B, Bean K, Jego B, Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care. 2007; 30: 2381-7.
10. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003; 108: 414-9.
11. Kahn SE, Zinman B, Haffner SM, O'NeillMC, Kravitz BG, YuD, et al.Obesity , O'Neill MC, Yu D, . is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes. 2006; 55: 2357-64.
12. Saijo Y, Kiyota N, Kawasaki Y, Miyazaki Y, Kashimura J, Fukuda M, et al. Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab. 2004; 6 (4): 249-58.
13. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 1999; 8: 1986-91.
14. Nishida M, Moriyama T, Sugita Y, Yamauchi T, Kihara K. Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men. Cardiovasc Diabetol. 2007; 6: 27.
15. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002; 89: 1117-9.
16. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J. 1996; 312: 1061-5.
17. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004; 140: 167-74.
18. Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004; 47 (8): 1403-10.
19. Gross JL. Microalbuminúria e a síndrome metabólica. Arq Bras Endrocrinol Metab. 2003; 47: 109-10.
20. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007; 3: 853-76.
21. Lin CC, Liu CS, Li TC, Chen CC, Li CI, Lin WY. Microalbuminuria and the metabolic syndrome and its components in the chinese population. Eur J Clin Invest. 2007; 37: 783-90.
22. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001; 344: 1959-65.